Alpha 2.0
Login Register
» Articles » PMID: 17329188

Is It Time to Consider Neoadjuvant Treatment As the Standard of Care in Oesophageal Cancer?

Overview
Journal Lancet Oncol
Specialty Oncology
Date 2007 Mar 3
PMID 17329188
Citations 8
Authors
Richard Greil
Hubert J Stein
Affiliations
Soon will be listed here.
Citing Articles

An A/C germline single-nucleotide polymorphism in the TNFAIP3 gene is associated with advanced disease stage and survival in only surgically treated esophageal cancer.

Ghadban T, Schmidt-Yang M, Smif M, Uzunoglu F, Perez D, Tsui T J Hum Genet. 2014; 59(12):661-6.

PMID: 25354935 DOI: 10.1038/jhg.2014.90.

Undervalued criteria in the evaluation of multimodal trials for upper GI cancers.

Brucher B, Kitajima M, Siewert J Cancer Invest. 2014; 32(10):497-506.

PMID: 25250506 PMC: 4266078. DOI: 10.3109/07357907.2014.958497.

Multidisciplinary approach for patients with esophageal cancer.

Villaflor V, Allaix M, Minsky B, Herbella F, Patti M World J Gastroenterol. 2012; 18(46):6737-46.

PMID: 23239911 PMC: 3520162. DOI: 10.3748/wjg.v18.i46.6737.

Neoadjuvant treatment of esophageal cancer.

Campbell N, Villaflor V World J Gastroenterol. 2010; 16(30):3793-803.

PMID: 20698042 PMC: 2921091. DOI: 10.3748/wjg.v16.i30.3793.

Gastroesophageal reflux disease: From heartburn to cancer.

Patti M, Waxman I World J Gastroenterol. 2010; 16(30):3743-4.

PMID: 20698034 PMC: 2921083. DOI: 10.3748/wjg.v16.i30.3743.